Xiang Gao is an alumina of Nanjing University. He received his Ph.D. degree from Thomas Jefferson University in 1994, then did his postdoctoral training at the Jackson Lab. In 2000, Xiang was recruited back as professor at Nanjing University. Where he founded both Model Animal Research Center of NJU and National Resource Center of Mutant Mice of China. He was the associate dean of Medical School and director for the State Key Laboratory of Pharmaceutical Biotechnology. Xiang is the recipient for Cheung Kong Scholar from Ministry of Education and Distinguished Young Scholar from National Science Foundation. His lab has been focused on understanding the physiological homeostasis of metabolic and immunological processes. He has been funded by multiple national grants and published more than 200 research papers. Xiang is recipient of many national and international awards, including the National Science and Technology Progress Award. In 2017, Xiang founded GemPharmatech (GPT) which has become the leading company for animal model generation and application. GPT is the largest mutant mouse resource center in the world and now holds more than 22,000 mutant mouse strains. GPT went IPO early this year at STAR market in Shanghai Exchange.